SETD4 Antibodies

Santa Cruz Biotechnology delivers a wide array of SETD4 monoclonal antibodies for research focused on understanding SETD4's role in cellular processes. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SETD4, a member of the SET domain-containing protein family, plays a significant role in histone methylation, which regulates gene expression and chromatin structure. SETD4 functions in cell cycle regulation and DNA damage response, making it a crucial target for cancer and disease-related studies. Research has shown SETD4's involvement in multiple biological pathways, highlighting its significance in cellular function. Investigating SETD4 advances our understanding of epigenetic regulation and its effects on cellular behavior. Recent studies have revealed new insights into SETD4's role in development and disease progression. Ongoing research continues to uncover novel functions of SETD4 in various biological processes. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of SETD4's role in human health and disease.